REFERENCES
1. Bousquet J, Anto JM, Bachert C, et al. Allergic rhinitis. Nat
Rev Dis Primers. 2020;6(1):95.
2. Wheatley LM, Togias A. Clinical practice. Allergic rhinitis. N
Engl J Med. 2015;372(5):456-463.
3. Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis.Lancet. 2011;378(9809):2112-2122.
4. Dierick BJH, van der Molen T, Flokstra-de Blok BMJ, et al. Burden and
socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food
allergy. Expert Rev Pharmacoecon Outcomes Res.2020;20(5):437-453.
5. Sultesz M, Horvath A, Molnar D, et al. Prevalence of allergic
rhinitis, related comorbidities and risk factors in schoolchildren.Allergy Asthma Clin Immunol. 2020;16(1):98.
6. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its
Impact on Asthma (ARIA) 2008 update (in collaboration with the World
Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63
Suppl 86:8-160.
7. Salo PM, Arbes SJ, Jr., Jaramillo R, et al. Prevalence of allergic
sensitization in the United States: results from the National Health and
Nutrition Examination Survey (NHANES) 2005-2006. J Allergy Clin
Immunol. 2014;134(2):350-359.
8. Meltzer EO, Blaiss MS, Derebery MJ, et al. Burden of allergic
rhinitis: results from the Pediatric Allergies in America survey.J Allergy Clin Immunol. 2009;124(3 Suppl):S43-70.
9. Bousquet PJ, Leynaert B, Neukirch F, et al. Geographical distribution
of atopic rhinitis in the European Community Respiratory Health Survey
I. Allergy. 2008;63(10):1301-1309.
10. Cruz AA, Popov T, Pawankar R, et al. Common characteristics of upper
and lower airways in rhinitis and asthma: ARIA update, in collaboration
with GA(2)LEN. Allergy. 2007;62 Suppl 84(s84):1-41.
11. Bousquet J, Schunemann HJ, Fonseca J, et al. MACVIA-ARIA Sentinel
NetworK for allergic rhinitis (MASK-rhinitis): the new generation
guideline implementation. Allergy. 2015;70(11):1372-1392.
12. Bousquet J, Schunemann HJ, Zuberbier T, et al. Development and
implementation of guidelines in allergic rhinitis - an ARIA-GA2LEN
paper. Allergy. 2010;65(10):1212-1221.
13. Bresciani M, Paradis L, Des Roches A, et al. Rhinosinusitis in
severe asthma. J Allergy Clin Immunol. 2001;107(1):73-80.
14. Meltzer EO, Blaiss MS, Naclerio RM, et al. Burden of allergic
rhinitis: allergies in America, Latin America, and Asia-Pacific adult
surveys. Allergy Asthma Proc. 2012;33 Suppl 1:S113-141.
15. Meltzer EO. Allergic Rhinitis: Burden of Illness, Quality of Life,
Comorbidities, and Control. Immunol Allergy Clin North Am.2016;36(2):235-248.
16. Demoly P, Maigret P, Elias Billon I, Allaert FA. Allergic rhinitis
increases the risk of driving accidents. J Allergy Clin Immunol.2017;140(2):614-616.
17. Demoly P, Bosse I, Maigret P. Perception and control of allergic
rhinitis in primary care. NPJ Prim Care Respir Med.2020;30(1):37.
18. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke
JP. The Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) statement: guidelines for reporting observational
studies. Lancet. 2007;370(9596):1453-1457.
19. Baiardini I, Pasquali M, Giardini A, et al. Rhinasthma: a new
specific QoL questionnaire for patients with rhinitis and asthma.Allergy. 2003;58(4):289-294.
20. Fonseca JA, Nogueira-Silva L, Morais-Almeida M, et al. Validation of
a questionnaire (CARAT10) to assess rhinitis and asthma in patients with
asthma. Allergy. 2010;65(8):1042-1048.
21. Nogueira-Silva L, Martins SV, Cruz-Correia R, et al. Control of
allergic rhinitis and asthma test–a formal approach to the
development of a measuring tool. Respir Res. 2009;10(1):52.
22. van der Leeuw S, van der Molen T, Dekhuijzen PN, et al. The minimal
clinically important difference of the Control of Allergic Rhinitis and
Asthma Test (CARAT): cross-cultural validation and relation with pollen
counts. NPJ Prim Care Respir Med. 2015;25(1):14107.
23. Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for
the Diagnosis, Management, and Prevention of Chronic Obstructive Lung
Disease 2017 Report: GOLD Executive Summary. Eur Respir J.2017;49(3).
24. Maio S, Baldacci S, Simoni M, et al. Impact of Asthma and Comorbid
Allergic Rhinitis on Quality of Life and Control in Patients of Italian
General Practitioners. J Asthma. 2012;49(8):854-861.
25. Groenewoud GC, de Groot H, van Wijk RG. Impact of occupational and
inhalant allergy on rhinitis-specific quality of life in employees of
bell pepper greenhouses in the Netherlands. Ann Allergy Asthma
Immunol. 2006;96(1):92-97.
26. Chen H, Cisternas MG, Katz PP, et al. Evaluating quality of life in
patients with asthma and rhinitis: English adaptation of the rhinasthma
questionnaire. Ann Allergy Asthma Immunol. 2011;106(2):110-118
e111.
27. Airaksinen LK, Luukkonen RA, Lindstrom I, Lauerma AI, Toskala EM.
Long-term exposure and health-related quality of life among patients
with occupational rhinitis. J Occup Environ Med.2009;51(11):1288-1297.
28. Haughney J, Price D, Kaplan A, et al. Achieving asthma control in
practice: understanding the reasons for poor control. Respir Med.2008;102(12):1681-1693.
29. de Groot EP, Nijkamp A, Duiverman EJ, Brand PL. Allergic rhinitis is
associated with poor asthma control in children with asthma.Thorax. 2012;67(7):582-587.
30. Chiron R, Vachier I, Khanbabaee G, et al. Impact of rhinitis on
asthma control in children: association with FeNO. J Asthma.2010;47(6):604-608.
31. Scadding G, Walker S. Poor asthma control?–then look up the nose.
The importance of co-morbid rhinitis in patients with asthma. Prim
Care Respir J. 2012;21(2):222-228.
32. Lemonnier N, Melen E, Jiang Y, et al. A novel whole blood gene
expression signature for asthma, dermatitis, and rhinitis multimorbidity
in children and adolescents. Allergy. 2020;75(12):3248-3260.
33. Massoth L, Anderson C, McKinney KA. Asthma and Chronic
Rhinosinusitis: Diagnosis and Medical Management. Med Sci
(Basel). 2019;7(4):53.
34. Price D, Zhang Q, Kocevar VS, Yin DD, Thomas M. Effect of a
concomitant diagnosis of allergic rhinitis on asthma-related health care
use by adults. Clin Exp Allergy. 2005;35(3):282-287.
35. Holgate S, Bisgaard H, Bjermer L, et al. The Brussels Declaration:
the need for change in asthma management. Eur Respir J.2008;32(6):1433-1442.
36. de Andrade CR, da Cunha Ibiapina C, Goncalves Alvim C, Fernandes
Fontes MJ, de Lima Belizario Facury Lasmar LM, Moreira Camargos PA.
Asthma and allergic rhinitis co-morbidity: a cross-sectional
questionnaire study on adolescents aged 13-14 years. Prim Care
Respir J. 2008;17(4):222-225.
37. Costa DJ, Bousquet PJ, Ryan D, et al. Guidelines for allergic
rhinitis need to be used in primary care. Prim Care Respir J.2009;18(4):250-257.
38. Tanno LK, Haahtela T, Calderon MA, Cruz A, Demoly P. Implementation
gaps for asthma prevention and control. Respir Med.2017;130:13-19.
Table 1: Descriptive statistics of the study patients overall and by
country